Kenvue Inc. (NYSE:KVUE) Receives Average Rating of “Hold” from Analysts

Shares of Kenvue Inc. (NYSE:KVUE) have been assigned a consensus recommendation of “Hold” from the sixteen analysts that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and seven have given a buy rating to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $24.85.

A number of research analysts recently commented on the stock. JPMorgan Chase & Co. lowered their price objective on shares of Kenvue from $25.00 to $24.00 and set an “overweight” rating on the stock in a research note on Friday, February 9th. Sanford C. Bernstein started coverage on Kenvue in a research note on Thursday, April 11th. They issued an “underperform” rating and a $18.00 price objective on the stock. The Goldman Sachs Group began coverage on shares of Kenvue in a research note on Friday, March 1st. They issued a “neutral” rating and a $20.00 price objective on the stock. Royal Bank of Canada reduced their target price on shares of Kenvue from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, February 9th. Finally, William Blair assumed coverage on Kenvue in a report on Wednesday, April 3rd. They issued a “market perform” rating on the stock.

Institutional Investors Weigh In On Kenvue

Several institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in shares of Kenvue by 1.5% during the 4th quarter. Vanguard Group Inc. now owns 148,880,588 shares of the company’s stock valued at $3,205,399,000 after acquiring an additional 2,226,390 shares during the last quarter. Price T Rowe Associates Inc. MD raised its position in shares of Kenvue by 19.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 109,327,221 shares of the company’s stock valued at $2,353,816,000 after purchasing an additional 18,118,056 shares during the period. FMR LLC lifted its stake in shares of Kenvue by 572.1% in the third quarter. FMR LLC now owns 89,182,980 shares of the company’s stock worth $1,790,794,000 after buying an additional 75,913,107 shares during the last quarter. Wellington Management Group LLP boosted its holdings in shares of Kenvue by 6.7% during the 4th quarter. Wellington Management Group LLP now owns 76,501,956 shares of the company’s stock worth $1,647,087,000 after buying an additional 4,815,126 shares during the period. Finally, Massachusetts Financial Services Co. MA lifted its position in Kenvue by 9.1% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 66,665,454 shares of the company’s stock worth $1,435,307,000 after acquiring an additional 5,574,265 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Kenvue Stock Up 1.6 %

NYSE KVUE opened at $19.58 on Friday. Kenvue has a 12 month low of $17.82 and a 12 month high of $27.80. The company’s fifty day moving average price is $19.83 and its two-hundred day moving average price is $20.16. The company has a current ratio of 1.12, a quick ratio of 0.78 and a debt-to-equity ratio of 0.69.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, February 8th. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.28 by $0.03. The firm had revenue of $3.67 billion for the quarter, compared to analysts’ expectations of $3.78 billion. Kenvue had a net margin of 9.87% and a return on equity of 15.62%. The company’s quarterly revenue was down 2.7% compared to the same quarter last year. Equities analysts anticipate that Kenvue will post 1.15 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, February 28th. Stockholders of record on Wednesday, February 14th were issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 4.09%. The ex-dividend date of this dividend was Tuesday, February 13th.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.